News Article
Laws and Regulations Committee Update - November 26, 2019
Posted on December 06, 2019
Blog:
November 26, 2019
Federal Register
Agricultural Marketing Service
Rules
Decreased Assessment Rate:
Marketing Order Regulating the Handling of Sweet Cherries Grown in Designated Counties in Washington
Filed on: 11/26/2019 at 8:45 am Scheduled Pub. Date: 11/27/2019
FR Document:2019-25650 PDF 16 Pages (334 KB) Permalink
Food Safety and Inspection Service
Rules
Publication Method for Lists of Foreign Countries Eligible to Export Meat, Poultry, or Egg Products to the United States
Filed on: 11/26/2019 at 8:45 am Scheduled Pub. Date: 11/27/2019
FR Document: 2019-25750 PDF 25 Pages (273 KB) Permalink
FDA
Recalls
|
Date |
Brand |
Product Description |
Type |
Reason/Problem |
Company |
|
11/25/2019 |
Yellowfin Tuna Medallions |
Food & Beverages, Fish |
Elevated Histamine Levels |
Northern Fisheries LTD |
Warning Letters
|
Posted Date |
Letter Issue Date |
Company Name |
Issuing Office |
Subject |
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Food Safety and Applied Nutrition (CFSAN) |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Food Safety and Applied Nutrition (CFSAN) |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Food Safety and Applied Nutrition (CFSAN) |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Drug Evaluation and Research | CDER |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Veterinary Medicine |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Food Safety and Applied Nutrition (CFSAN) |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Food Safety and Applied Nutrition (CFSAN) |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Food Safety and Applied Nutrition (CFSAN) |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
|
|
11/25/2019 |
11/22/2019 |
Center for Food Safety and Applied Nutrition (CFSAN) |
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products |
FSIS
USDA's Recommendations for a Safe Thanksgiving
OMB
The 2019 Fall Agenda was published on 11/20/2019
APHIS
USDA
USDA Statement on U.S. Sugar Market
@FrankYiannasFDA
- · How do we reach a new era of smarter #foodsafety? Check out this quote from @FrankYiannasFDA of @US_FDA at #gfsi19 and read more in our executive summary: https://bit.ly/2QS9jnJ #futureoffood
@Dr.AbernethyFDA
- · FDA is quickly working to further clarify our regulatory approach for products containing cannabis and cannabis-derived compounds like CBD. We’re doing this in line with our overarching approach like for any other substance FDA regulates.
- · In the meantime, we’re monitoring the marketplace and taking action as needed, like issuing 15 warning letters today to companies that violate the law in ways that raise public health concerns.
- · Often, people wrongly think that the myriad of CBD products on the market have been evaluated by FDA and determined to be safe, or that trying CBD can’t hurt. Aside from one prescription drug, CBD products have not been approved by FDA.
- · There are number of questions regarding CBD’s safety and there are real risks that need to be considered. There is significant interest in CBD and we must work together to fill in the knowledge gaps about the science, safety and quality of many of these products.
@FDArecalls
- · Northern Fisheries LTD. Voluntary Expanded Tuna Recall Press Release https://go.usa.gov/xpRjE
@US_FDA
- · FDA took several actions today on CBD including issuing 15 warning letters, updating on safety concerns, and given the lack of scientific information, that FDA cannot conclude CBD is generally recognized as safe for use in human or animal food https://go.usa.gov/xpRXj